Medline Inc. (MDLN) PE Ratio: 30.69
Is Medline Inc.’s P/E ratio high or low?
Medline Inc.'s P/E ratio of 30.69 is in line with its 1-year average of 31.63, around the middle of its 1-year range (24.09–39.88).
As of Thursday, June 11, 2026. 2.97% below its 12-month average of 31.63.
PE Ratio (30.69) = Close Price ($37.13) / Diluted TTM EPS ($1.21)
MDLN PE Ratio Chart
MDLN Average PE Ratio Chart
MDLN Current vs Average PE Ratio Chart
MDLN PE Ratio Metrics
PE RATIO
30.69
PE RATIO AVG TTM
31.63
PE RATIO AVG 3Y
31.63
PE RATIO AVG 5Y
31.63
PE RATIO AVG 10Y
31.63
PE RATIO AVG 15Y
31.63
PE RATIO AVG 20Y
31.63
CURRENT VS TTM AVG
-2.97%
CURRENT VS 3Y AVG
-2.97%
CURRENT VS 5Y AVG
-2.97%
CURRENT VS 10Y AVG
-2.97%
CURRENT VS 15Y AVG
-2.97%
CURRENT VS 20Y AVG
-2.97%
MDLN Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $31.40B | 30.69 | 31.63 | 31.63 | 31.63 |
| Centene Corporation (CNC) | $32.26B | N/A | 8.90 | 15.70 | 23.23 |
| IQVIA Holdings Inc. (IQV) | $30.08B | 22.40 | 25.98 | 29.30 | 38.41 |
| Biogen Inc. (BIIB) | $28.94B | 20.90 | 16.56 | 18.50 | 18.66 |
| DexCom, Inc. (DXCM) | $28.92B | 32.03 | 41.88 | 71.49 | 113.52 |
| Zoetis Inc. (ZTS) | $34.27B | 13.56 | 22.06 | 30.43 | 35.41 |
| Agilent Technologies, Inc. (A) | $36.21B | 26.43 | 29.35 | 29.81 | 32.77 |
| Veeva Systems Inc. (VEEV) | $26.31B | 29.19 | 47.10 | 54.65 | 66.86 |
| Waters Corporation (WAT) | $23.21B | 46.15 | 31.91 | 30.92 | 30.43 |
| United Therapeutics Corporation (UTHR) | $23.15B | 20.16 | 17.03 | 14.93 | 16.04 |
P/E vs. its own history
At 30.7, P/E is in its normal range, sitting higher than 52% of its 1-year history.
1-year low
24.1
median
30.6
1-year high
39.9
P/E Comparison
Trailing P/E
30.7
Forward P/E
22.4
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$37.13
Forward EPS (Est.)
$1.66
Forward P/E
22.39
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Medline Inc. PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medline Inc. PE Ratio FAQ
- What is the P/E ratio for Medline Inc. (MDLN)?
- The P/E ratio for MDLN stock is 30.69.
- Is Medline Inc.'s P/E ratio high or low?
- Medline Inc.'s P/E ratio of 30.69 is in line with its 1-year average of 31.63, around the middle of its 1-year range (24.09–39.88).
- What is the TTM average P/E ratio for Medline Inc. (MDLN)?
- The TTM average P/E ratio for MDLN stock is 31.63.
- What is the 3Y average P/E ratio for Medline Inc. (MDLN)?
- The 3Y average P/E ratio for MDLN stock is 31.63.
- What is the 5Y average P/E ratio for Medline Inc. (MDLN)?
- The 5Y average P/E ratio for MDLN stock is 31.63.
- What is the 10Y average P/E ratio for Medline Inc. (MDLN)?
- The 10Y average P/E ratio for MDLN stock is 31.63.
- What is the 15Y average P/E ratio for Medline Inc. (MDLN)?
- The 15Y average P/E ratio for MDLN stock is 31.63.
- What is the 20Y average P/E ratio for Medline Inc. (MDLN)?
- The 20Y average P/E ratio for MDLN stock is 31.63.
Medline Inc. PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2026-06-11 | 30.69 |
| 2026-06-10 | 30.20 |
| 2026-06-09 | 29.76 |
| 2026-06-08 | 27.93 |
| 2026-06-05 | 27.78 |
| 2026-06-04 | 28.47 |
| 2026-06-03 | 28.49 |
| 2026-06-02 | 27.43 |
| 2026-06-01 | 29.55 |
| 2026-05-29 | 30.21 |
| 2026-05-28 | 30.41 |
| 2026-05-27 | 29.62 |
| 2026-05-26 | 29.88 |
| 2026-05-22 | 30.59 |
| 2026-05-21 | 30.66 |
| 2026-05-20 | 29.96 |
| 2026-05-19 | 31.16 |
| 2026-05-18 | 29.77 |
| 2026-05-15 | 29.91 |
| 2026-05-14 | 32.15 |
| 2026-05-13 | 31.99 |
| 2026-05-12 | 31.86 |
| 2026-05-11 | 32.44 |
| 2026-05-08 | 32.66 |
| 2026-05-07 | 34.60 |
| 2026-05-06 | 34.72 |
| 2026-05-05 | 37.45 |
| 2026-05-04 | 36.52 |
| 2026-05-01 | 36.98 |
| 2026-04-30 | 36.75 |
| 2026-04-29 | 35.87 |
| 2026-04-28 | 36.56 |
| 2026-04-27 | 37.38 |
| 2026-04-24 | 36.99 |
| 2026-04-23 | 38.21 |
| 2026-04-22 | 38.98 |
| 2026-04-21 | 39.26 |
| 2026-04-20 | 39.88 |
| 2026-04-17 | 39.37 |
| 2026-04-16 | 38.79 |
| 2026-04-15 | 39.61 |
| 2026-04-14 | 39.40 |
| 2026-04-13 | 39.02 |
| 2026-04-10 | 37.69 |
| 2026-04-09 | 37.76 |
| 2026-04-08 | 36.64 |
| 2026-04-07 | 35.64 |
| 2026-04-06 | 36.26 |
| 2026-04-02 | 36.60 |
| 2026-04-01 | 36.36 |
| 2026-03-31 | 36.78 |
| 2026-03-30 | 35.22 |
| 2026-03-27 | 28.52 |
| 2026-03-26 | 29.11 |
| 2026-03-25 | 29.43 |
| 2026-03-24 | 28.99 |
| 2026-03-23 | 29.30 |
| 2026-03-20 | 29.47 |
| 2026-03-19 | 30.06 |
| 2026-03-18 | 29.14 |
| 2026-03-17 | 29.08 |
| 2026-03-16 | 28.79 |
| 2026-03-13 | 28.59 |
| 2026-03-12 | 28.32 |
| 2026-03-11 | 29.23 |
| 2026-03-10 | 29.57 |
| 2026-03-09 | 29.94 |
| 2026-03-06 | 30.23 |
| 2026-03-05 | 30.38 |
| 2026-03-04 | 29.57 |
| 2026-03-03 | 30.61 |
| 2026-03-02 | 31.62 |
| 2026-02-27 | 32.77 |
| 2026-02-26 | 33.72 |
| 2026-02-25 | 33.23 |
| 2026-02-24 | 34.48 |
| 2026-02-23 | 34.23 |
| 2026-02-20 | 34.34 |
| 2026-02-19 | 32.83 |
| 2026-02-18 | 32.90 |
| 2026-02-17 | 31.83 |
| 2026-02-13 | 30.72 |
| 2026-02-12 | 30.75 |
| 2026-02-11 | 31.06 |
| 2026-02-10 | 31.23 |
| 2026-02-09 | 32.67 |
| 2026-02-06 | 32.62 |
| 2026-02-05 | 31.86 |
| 2026-02-04 | 31.01 |
| 2026-02-03 | 30.84 |
| 2026-02-02 | 31.05 |
| 2026-01-30 | 30.48 |
| 2026-01-29 | 30.16 |
| 2026-01-28 | 30.57 |
| 2026-01-27 | 31.94 |
| 2026-01-26 | 30.92 |
| 2026-01-23 | 31.72 |
| 2026-01-22 | 31.70 |
| 2026-01-21 | 29.86 |
| 2026-01-20 | 30.45 |
| 2026-01-16 | 30.43 |
| 2026-01-15 | 29.46 |
| 2026-01-14 | 29.94 |
| 2026-01-13 | 29.55 |
| 2026-01-12 | 29.46 |
| 2026-01-09 | 27.94 |
| 2026-01-08 | 28.45 |
| 2026-01-07 | 27.88 |
| 2026-01-06 | 27.43 |
| 2026-01-05 | 26.90 |
| 2026-01-02 | 28.01 |
| 2025-12-31 | 28.97 |
| 2025-12-30 | 25.56 |
| 2025-12-29 | 25.61 |
| 2025-12-26 | 26.91 |
| 2025-12-24 | 27.00 |
| 2025-12-23 | 26.60 |
| 2025-12-22 | 25.72 |
| 2025-12-19 | 25.40 |
| 2025-12-18 | 24.09 |
| 2025-12-17 | 25.00 |
Related Metrics
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle